GlaxoSmithKline still has questions to answer over bribery case in China

22nd September 2014

It’s good news that Mark Reilly is not going to prison – but what of GSK chief executive Sir Andrew Witty’s ethical agenda?

GlaxoSmithKline has made a grovelling apology to “the Chinese government and the Chinese people” and will pay a fine of almost £300m for bribing doctors.

Humiliating stuff, especially for a FTSE 100 company whose chief executive, Sir Andrew Witty, preaches an ethical agenda.

But this case was never simply about GSK’s wrongdoings, reputation or the size of the fine.

Read more at source article

Leave a Reply

Your email address will not be published.

92 − 87 =

« back to posts